Search 

A number of companies shown here with profiles and logos are financially supported by the UK government's Tradeshow Access Programme.

Established in 1989, the BIA (BioIndustry Association) exists to encourage and promote a financially sound and thriving bioscience sector within the UK economy and concentrates its efforts on emerging enterprise and the related interests of companies Founded over 20 years ago at the infancy of biotechnology, the BIA is the trade association for innovative enterprises involved in UK bioscience. Members include emerging and more established bioscience companies; pharmaceutical companies; academic, research and philanthropic organisations; and service providers to the bioscience sector. The BIA represents the interests of its members to a broad section of stakeholders, from government and regulators to patient groups and the media. Our goal is to secure the UK's position as a global hub and as the best location for innovative research and commercialisation, enabling our world-leading research base to deliver healthcare solutions that can truly make a difference to people's lives.

Exhibiting at Booth 38

BioPartner UK leads the UK Delegation to several partnering conferences
each year. It is a UK Accredited Trade Organisation facilitating international partnering for trade, investment and collaborations with Life Sciences organisations across the UK. BioPartner is a membership organisation, supporting UK SMEs and startups, and signposting organisations worldwide to UK expertise.

BioPartner has alliances with organisers of international biopartnering events, and with UK membership organisations, operating both independently and
in partnership with the UK government. BioPartner disseminates tradeshow access grants to help UK-based SMEs exhibit their services and products in new overseas markets. 

Invest Liverpool is the Mayor of Liverpool’s economic investment agency. Invest Liverpool offers a range of services to support companies looking to collaborate, expand or invest in Liverpool City Region. Health & Life Sciences is a priority sector and we welcome conversations about investing in the industry.

We are investing billions of pounds in our health ecosystem, offering countless opportunities from research, drug discovery, and clinical trials through to bio-manufacturing.

Investment in health and life sciences is driving innovation in specialist areas such as: Infection, Precision Medicine, Children’s Health, Veterinary Science, Healthy and Independent Living, Big Data, Sensors and Internet of Things.

With hundreds of medical companies based here, the area is part of the Liverpool-Manchester life sciences corridor, one of the UK’s top three clusters of biomedical activity.

Health and Life Sciences companies that share our passion for research and discovery will be impressed by the quality and quantity of world-class R&D that is conducted here. Our schools, colleges and universities are working alongside big pharma and start-ups to build an exceptional talent pool.

Invest Liverpool welcomes conversations with companies about investing in health and life sciences.

Exhibiting at Booth 39

The Northern Powerhouse is home to over 15 million people, a quarter of the UK population, and 13.3% of the UK’s Gross Value Add.

The North of England is home to a vibrant and well connected industrial, academic and clinical health and life sciences ecosystem and is home to nearly 25% of all life sciences businesses in the UK:
1,100 life science businesses employing more than 40,000 highly skilled people.

£17.5bn annual contribution to the UK economy.
44% of all UK pharmaceutical exports.

The North’s N8 universities have an annual income of £1.2bn a year, generating £12.2bn and creating 119,000 jobs.
570,000 employed in health sciences across the North – 7.5% of the region’s workforce.

Leading the UK in clinical trials delivery including the only real-world clinical trial - the Salford Lung Study.

Home to global brands (including AstraZeneca, GSK, Eli Lilly, Procter & Gamble, Medimmune, Allergan, Unilever, Sanofi Aventis, Smith and Nephew, Johnson and Johnson and many more).
The Life Sciences in the Northern Powerhouse delegation at BioEurope 2017 consists of representatives from academic, business and clinical communities and includes: Aptus Clinical, Alderley Park, Health Innovation Manchester, Invest Liverpool, Peak Proteins, Seda Pharmaceutical Development Services and Northern Health Science Alliance which has been brought together by Bionow and the Northern Health Science Alliance.

Websites: www.bionow.co.uk and www.thenhsa.co.uk

MediWales is the life science network for Wales, a not-for-profit, independent company that creates business opportunities and partnerships for our members. We support 180 members from the medical technology, diagnostic and pharmaceutical industries, NHS health boards, university departments and professional services and suppliers. We create collaboration through our popular programme of events that focus on strategic issues for the life science industry, including regulatory updates, market access, finance and funding, clinical unmet needs and international trade.

One Nucleus is a membership organisation for international life science and healthcare companies. We are based in Cambridge and London UK, the heart of Europe’s largest life science and healthcare cluster.

Established in 1997, and formerly known as ERBI, One Nucleus is a not-for-profit, membership organisation and located in Cambridge and London – the centre of Europe’s leading life science and healthcare cluster. More than 470 members include pharmaceutical, biotech, medical device and diagnostic companies and associated technical and commercial service providers.

At Scottish Development International (SDI) we’re all about discovery: helping ambitious businesses like yours discover an exciting new chapter in Scotland. We’re here to help you discover new business opportunities, markets, ventures and people. From tech to fintech to chemical science and digital technology, we’ve helped over 5135 inward investors to realise their ambitions in Scotland.